Press Releases

The drug tezepelumab was shown to significantly reduce exacerbations in people with severe asthma in clinical trials. Now, a new study presented at the 2026 ATS International Conference shows that it is also safe and effective in real-world patients. “Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE Study” will be published in the American Journal of Respiratory and Critical Care Medicine online on May 18.

American Thoracic Society Joins FIRS Partners in this Call for Action on World Asthma Day

Major quality improvement study spanning seven academic medical systems aims to address widespread underdiagnosis of bronchiectasis, a serious and underrecognized lung disease, with support from Insmed Incorporated.

The American Thoracic Society – along with 16 health, community and environmental groups – filed a lawsuit today in the U.S. District Court for the Northern District of California against the Environmental Protection Agency for failing to implement the strengthened 2024 national ambient air quality standard (NAAQS) for particulate matter air pollution, commonly known as soot.

The new pledge of support for the Public Advisory Roundtable (PAR), the patient arm of the ATS, will help the 25-year-old initiative elevate patient care in the next era of medicine.

Even brief exposure can trigger lung injury, infections, and long-term breathing problems in the public

World AIDS Day reminds us that collaboration is necessary to slow TB resurgence: Forum of International Respiratory Societies.

The Forum of International Respiratory Societies Recognizes World COPD Day with the Theme, “Short of Breath, Think COPD.”

Forum of International Respiratory Societies Calls for Immediate Action to Prevent Childhood Pneumonia on World Pneumonia Day 2025

Likely the most important advance since the 2019 guideline from the American Thoracic Society, this latest iteration includes a framework to provide more targeted treatment.